Thank you, Luc. I'd like to begin with a summary of our financial results for the second quarter on Slide 5. Once again, we delivered a strong quarter, and we are very pleased with the company's ongoing execution and focus on addressing key trends in the market. Our Q2 financial results were in line with our revenue expectations and at the high end of our earnings expectations as we further strengthened our balance sheet with continued strong cash generation in the quarter. As Luc discussed, we announced that we entered into a definitive agreement with Cadence to divest our PHY IP business, and we expect the transaction to close in Q3. We are pleased with this transaction as it will allow us to redeploy our investments into higher growth areas of digital IP and products. Let me walk you through our non-GAAP income statement on Slide 6. Revenue for the second quarter was $119.8 million, in line with our expectations. Royalty revenue was $40.7 million while licensing billings was $60.2 million. The difference between licensing billings and royalty revenue primarily relates to timing as we don't always recognize revenue in the same quarter as we bill our customers. Product revenue was $55 million, consisting primarily of memory interface chips. Contract and other revenue was $24.1 million, consisting primarily of silicon IP. As a reminder, only a portion of our silicon IP revenue is reflected in contract and other revenue and the remaining portion is reported in royalty revenue as well as in licensing billings. Total operating costs, including cost of goods sold for the quarter was $75.7 million. Operating expenses of $55.9 million were lower than our expectations as we continue to be vigilant in our expense management and we ended the quarter with a total headcount of 724. Non-GAAP interest and other income for the second quarter was $1.9 million. This included $600,000 of ASC 606 interest income related to the financing component of fixed fee licensing arrangements for which we have recognized revenue, but not yet received payment. Excluding the financing interest income related to ASC 606, this would have been $1.2 million of net interest income. Using an assumed flat tax rate of 24% for non-GAAP pretax income, non-GAAP net income for the quarter was $34.9 million. Now let me turn to the balance sheet details on Slide 7. We ended the quarter with cash, cash equivalents and marketable securities totaling $332.6 million up from the previous quarter, primarily through cash from operations of $50.4 million. At the end of Q2, we had contract assets worth $97.9 million which reflect the net present value of unbilled accounts receivable related to licensing arrangements for which the company has no future performance obligations. We expect this number to continue to trend down as we bill and collect for these contracts. It is important to note that this metric does not represent the entire value of our existing licensing agreements, as each renewal opportunity, we work to restructure our patent agreements in a manner that allows us to recognize revenue each quarter during the life of each agreement. Second quarter CapEx was at $11.5 million while depreciation expense was $7.8 million. We delivered $39 million of free cash flow in the quarter. Now let me turn to our guidance for the third quarter on Slide 8. As a reminder, the forward-looking guidance reflects our current best estimates at this time. We continue to actively monitor the macro environment and our actual results could differ materially from what I'm about to review. In addition to the financial outlook under ASC 606, we also provide information on licensing billings, which is an operational metric that reflects amounts invoiced to our licensing customers during the period adjusted for certain differences. As we have reported historically, licensing billings closely correlates with what we had historically reported as royalty revenue under ASC 605. Our guidance for the quarter includes our PHY IP business. On a quarterly basis, the business is running breakeven as approximately $6 million in revenue is offset with $6 million in cost. Under ASC 606, we expect revenue in the third quarter between $96 million and $102 million. We expect royalty revenue between $26 million and $32 million and licensing billings between $59 million and $65 million. We have made a lot of progress with our product business, and we are well positioned in the market to deliver long-term profitable growth, while maintaining a competitive position and share gains. As Luc mentioned earlier, the DDR5 product transition is underway. However, our product revenue guidance continues to be impacted by DDR4 inventory digestion. We expect this transition to continue to impact us through the remainder of the year. We expect Q3 non-GAAP total operating costs, which includes COGS to be between $75 million and $71 million. We expect Q3 CapEx to be approximately $10 million. Under ASC 606, non-GAAP operating results for the third quarter is expected to be between a profit of $21 million and $31 million. For non-GAAP interest and other income and expense, which excludes interest income related to ASC 606, we expect $1 million of interest income. We expect the pro forma tax rate to remain at approximately 24%. The 24% is higher than the statutory tax rate of 21%, primarily due to higher tax rates in our foreign jurisdictions. As a reminder, we pay approximately $20 million of cash taxes each year driven primarily by licensing agreements with our partners in Korea. We expect non-GAAP taxes to be between an expense of $5 million and $8 million in Q3. We expect Q3 share count to be 112 million basic and diluted shares outstanding. Overall, we anticipate a non-GAAP earnings per share range between $0.15 and $0.21 for the quarter. Let me finish with a summary on Slide 9. I am pleased with our strong results and the team's continued execution in this challenging and unpredictable macroeconomic environment as we continue to make progress against our strategic initiatives. We have a diversified portfolio with a stable and predictable backbone from our patent licensing business. Our product portfolio is well positioned to capture growing opportunities in the data center fueled by AI. We continue to deliver value to our shareholders with our strong innovation, a robust balance sheet and strong cash generation. Before I open up the call to Q&A, I would like to thank our employees for their continued teamwork and execution. With that, I'll turn the call back to our operator to begin Q&A. Can we have our first question?